Usana Health Sciences Stock Alpha and Beta Analysis

USNA Stock  USD 19.57  0.08  0.41%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as USANA Health Sciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in USANA Health over a specified time horizon. Remember, high USANA Health's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to USANA Health's market risk premium analysis include:
Beta
(0.72)
Alpha
(0.38)
Risk
2.16
Sharpe Ratio
(0.02)
Expected Return
(0.03)
Please note that although USANA Health alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, USANA Health did 0.38  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of USANA Health Sciences stock's relative risk over its benchmark. USANA Health Sciences has a beta of 0.72  . As returns on the market increase, returns on owning USANA Health are expected to decrease at a much lower rate. During the bear market, USANA Health is likely to outperform the market. At present, USANA Health's Book Value Per Share is projected to increase based on the last few years of reporting. The current year's Tangible Book Value Per Share is expected to grow to 22.10, whereas Price Book Value Ratio is forecasted to decline to 2.27.

Enterprise Value

1.26 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out USANA Health Backtesting, USANA Health Valuation, USANA Health Correlation, USANA Health Hype Analysis, USANA Health Volatility, USANA Health History and analyze USANA Health Performance.

USANA Health Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. USANA Health market risk premium is the additional return an investor will receive from holding USANA Health long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in USANA Health. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate USANA Health's performance over market.
α-0.38   β-0.72

USANA Health expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of USANA Health's Buy-and-hold return. Our buy-and-hold chart shows how USANA Health performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

USANA Health Market Price Analysis

Market price analysis indicators help investors to evaluate how USANA Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading USANA Health shares will generate the highest return on investment. By understating and applying USANA Health stock market price indicators, traders can identify USANA Health position entry and exit signals to maximize returns.

USANA Health Return and Market Media

The median price of USANA Health for the period between Fri, Oct 10, 2025 and Thu, Jan 8, 2026 is 20.0 with a coefficient of variation of 9.17. The daily time series for the period is distributed with a sample standard deviation of 1.88, arithmetic mean of 20.46, and mean deviation of 1.1. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
USANA Reports Q3 In Line With Expectations But Stock Drops 10.2
10/22/2025
2
Proven Power for Strong Bone Support--USANAs MagneCal D Earns ConsumerLab.com Seal of Approval
11/11/2025
3
Will USANA Health Sciences Inc. stock sustain high P E ratios - July 2025 Chart Watch Free Reliable Trade Execution Plans - newser.com
11/18/2025
4
1 Value Stock with Competitive Advantages and 2 We Avoid
11/24/2025
5
On National Make-a-Gift Day, Kevin Guest Says the Most Meaningful Gifts Are the Ones Money Cant Buy
12/03/2025
6
3 Stocks Under 50 We Find Risky
12/05/2025
7
Disposition of 2673 shares by Peter Benedict of USANA Health at 20.9506 subject to Rule 16b-3
12/10/2025
8
USANA Health Sciences Upgraded at Zacks Research - MarketBeat
12/11/2025
9
Head to Head Contrast USANA Health Sciences NLS Pharmaceutics
12/16/2025

About USANA Health Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including USANA or other stocks. Alpha measures the amount that position in USANA Health Sciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2022 2023 2025 2026 (projected)
Days Sales Outstanding2.642.852.573.11
PTB Ratio2.362.082.392.27

USANA Health Upcoming Company Events

As portrayed in its financial statements, the presentation of USANA Health's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, USANA Health's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of USANA Health's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of USANA Health. Please utilize our Beneish M Score to check the likelihood of USANA Health's management manipulating its earnings.
6th of February 2024
Upcoming Quarterly Report
View
23rd of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with USANA Health

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether USANA Health Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of USANA Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Usana Health Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Usana Health Sciences Stock:
USANA Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of USANA Health technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of USANA Health trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...